These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1173535)

  • 41. Pharmacokinetic study of amphetamine elimination in dogs and swine.
    Baggot JD; Davis LE
    Biochem Pharmacol; 1972 Jul; 21(14):1967-76. PubMed ID: 4649345
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of diethylaminoethyl diphenylpropyl-acetate hydrochloride (SKF-525A) on the norepinephrine-depleting actions of d-amphetamine.
    Clay GA; Cho AK; Roberfroid M
    Biochem Pharmacol; 1971 Aug; 20(8):1821-31. PubMed ID: 4109535
    [No Abstract]   [Full Text] [Related]  

  • 43. Elevation of amphetamine levels in rat brain after administration of the choline acetyltransferase inhibitor 4-(1-Naphthylvinyl) pyridine (NVP).
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1975 Jun; 215(2):197-201. PubMed ID: 1164087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.
    Magour S; Coper H; Fähndrich C
    Pol J Pharmacol Pharm; 1976; 28(6):589-92. PubMed ID: 1012982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indomethacin potentiates the operant behavior suppressant and rectal temperature lowering effects of low doses of d-amphetamine in rats.
    Nielsen JA; Sparber SB
    Pharmacol Biochem Behav; 1984 Aug; 21(2):219-24. PubMed ID: 6483934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inability of rat brain homogenate to oxidize amphetamine.
    Maickel RP; Harrison SD
    Biochem Pharmacol; 1974 Mar; 23(6):1146-7. PubMed ID: 4824914
    [No Abstract]   [Full Text] [Related]  

  • 47. [Blood-brain barrier: I. Kinetics of the distribution of amphetamine H3-in brain structures of the rate after intravenous administration].
    Lindenbaum A; Marcher K; Wepierre J; Cohen Y
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):337-47. PubMed ID: 4614730
    [No Abstract]   [Full Text] [Related]  

  • 48. Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation.
    Simpson LL
    J Pharmacol Exp Ther; 1975 Apr; 193(1):149-59. PubMed ID: 1133761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic and experimental factors in the behavioral response to repeated amphetamine.
    Browne RG; Segal DS
    Pharmacol Biochem Behav; 1977 May; 6(5):545-52. PubMed ID: 561406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regional brain distribution of alpha-amphetamine in lead-exposed rats.
    Zenick H; Lasley SM; Greenland R; Caruso V; Succop P; Price D; Michaelson IA
    Toxicol Appl Pharmacol; 1982 Jun; 64(1):52-63. PubMed ID: 7112584
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of neuroleptics on amphetamine metabolism in the rat and guinea-pig.
    Yokel RA
    J Pharm Pharmacol; 1978 Nov; 30(11):719-21. PubMed ID: 31438
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of desmethylimipramine, iprindole and DL-erythro-alpha-(3,4-dichlorophenyl)-beta-(t-butyl amino) propanol HC1 on the metabolism of amphetamine.
    Lemberger L; Sernatinger E; Kuntzman R
    Biochem Pharmacol; 1970 Dec; 19(12):3021-8. PubMed ID: 5513039
    [No Abstract]   [Full Text] [Related]  

  • 53. The metabolism in vitro and hepatic microsomal interactions of some enantiomeric drug substrates.
    Hewick DS; Fouts JR
    Biochem J; 1970 May; 117(5):833-41. PubMed ID: 4393781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex related differences in the physiological disposition of amphetamine and its metabolites in the rat.
    Meyer EM; Lytle LD
    Proc West Pharmacol Soc; 1978; 21():313-6. PubMed ID: 693514
    [No Abstract]   [Full Text] [Related]  

  • 55. Deuterium isotope effects in the metabolism of N-alkylsubstituted amphetamines in man.
    Vree TB; Gorgels JP; Muskens AT; van Rossum JM
    Clin Chim Acta; 1971 Sep; 34(2):333-44. PubMed ID: 5113570
    [No Abstract]   [Full Text] [Related]  

  • 56. Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain.
    Rassoulpour A; Wu HQ; Poeggeler B; Schwarcz R
    Brain Res; 1998 Aug; 802(1-2):111-8. PubMed ID: 9748528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions.
    Kennedy LA; Zigmond MJ
    Brain Res; 1979 May; 168(2):408-13. PubMed ID: 221074
    [No Abstract]   [Full Text] [Related]  

  • 58. Glucose regulates [3H](+)-amphetamine binding and Na+K+ ATPase activity in the hypothalamus: a proposed mechanism for the glucostatic control of feeding and satiety.
    Hauger R; Hulihan-Giblin B; Angel I; Luu MD; Janowsky A; Skolnick P; Paul SM
    Brain Res Bull; 1986 Feb; 16(2):281-8. PubMed ID: 3008957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amphetamine toxicity in hyperthyroid mice: effects on endogenous catecholamines.
    Moore KE
    Biochem Pharmacol; 1965 Dec; 14(12):1831-7. PubMed ID: 5880538
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C; Iversen SD; Iversen LL
    Eur J Pharmacol; 1971 May; 14(4):351-9. PubMed ID: 4400534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.